Entrada Therapeutics, Inc.

TRDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001689375

SEC filings (opens in a new tab)

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Entrada Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of TRDA: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	119	1	128	+10
Shares	25.5M	6.79K	29.1M	+3.61M (+14.2%)
Value	$321.4M	$85.7K	$214.4M	−$107.0M (−33.3%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Entrada Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to TRDA in Q2 2026
Institution	Shares	Value	% of portfolio
Merck & Co., Inc.	1,739,768	$12.8M	2.43%
MPM Oncology Impact Management LP	1,253,053	$9.22M	0.56%
Gsa Capital Partners LLP	88,005	$648.0K	0.04%
Susquehanna Portfolio Strategies, LLC	54,113	$398.3K	0.01%
Y-Intercept (Hong Kong) Ltd	34,687	$255.3K	0.01%
Graham Capital Management, L.P.	33,457	$246.2K	0.01%
Odyssean, LLC	31,305	$230.4K	0.04%
Ieq Capital, LLC	29,679	$218.4K	0.00%
Point72 Asset Management, L.P.	28,500	$209.8K	0.00%
Verdad Advisers, LP	27,500	$202.4K	0.19%
Voleon Capital Management LP	25,324	$186.4K	0.00%
Jump Financial, LLC	24,072	$177.2K	0.00%
Mariner, LLC	21,707	$159.8K	0.00%
Mercer Global Advisors Inc	20,653	$152.0K	0.00%
Panagora Asset Management Inc	15,493	$114.0K	0.00%
Cerity Partners LLC	13,511	$99.4K	0.00%
Wealth Enhancement Advisory Services, LLC	12,769	$88.4K	0.00%
State of Wyoming	5,014	$36.9K	0.00%
STRS Ohio	3,200	$23.6K	0.00%
Federated Hermes, Inc.	1,968	$14.5K	0.00%
Clearstead Advisors, LLC	141	$1.04K	0.00%
Zions Bancorporation, National Association	87	$640	0.00%
Caitong International Asset Management Co., Ltd	46	$339	0.00%
Wealth Enhancement Trust Services, Inc.	43	$316	0.00%
Quarry LP	25	$184	0.00%
SBI Securities Co., Ltd.	2	$15	0.00%

Sold out (16)

Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of TRDA in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Jones Hill Capital LP	374,010	$4.72M
Acuta Capital Partners, LLC	89,358	$1.13M
Marshall Wace, LLP	53,764	$678.5K
Jane Street Group, LLC	37,213	$469.6K
Creative Planning	22,230	$280.5K
Shay Capital LLC	21,548	$271.9K
Susquehanna International Group, LLP	20,315	$256.4K
Canada Pension Plan Investment Board	17,700	$223.4K
Dynamic Technology Lab Private Ltd	16,474	$207.9K
Franklin Resources Inc	11,102	$140.1K
IHT Wealth Management, LLC	11,100	$140.1K
Signaturefd, LLC	208	$2.63K
US Bancorp	70	$883
MAI Capital Management	54	$682
Wealth Preservation Advisors, LLC	22	$278
Quadrant Capital Group LLC	18	$228

Not filed for Q2 2026 yet (1)

Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TRDA in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	6,788	$85.7K